PYLARIFY Trademark

Trademark Overview

On Tuesday, October 8, 2019, a trademark application was filed for PYLARIFY with the United States Patent and Trademark Office. The USPTO has given the PYLARIFY trademark a serial number of 88978293. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Monday, December 1, 2025. This trademark is owned by Progenics Pharmaceuticals, Inc.. The PYLARIFY trademark is filed in the Pharmaceutical Products category with the following description:

Radiopharmaceutical imaging and detection agents for detection, diagnosing and monitoring cancer; pharmaceutical preparations for the detection, diagnosis and monitoring of cancer
pylarify

General Information

Serial Number88978293
Word MarkPYLARIFY
Filing DateTuesday, October 8, 2019
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateMonday, December 1, 2025
Registration Number6120752
Registration DateTuesday, August 4, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 25, 2020

Trademark Statements

Goods and ServicesRadiopharmaceutical imaging and detection agents for detection, diagnosing and monitoring cancer; pharmaceutical preparations for the detection, diagnosis and monitoring of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 15, 2019
Primary Code005
First Use Anywhere DateTuesday, June 9, 2020
First Use In Commerce DateTuesday, June 9, 2020

Trademark Owner History

Party NameProgenics Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBedford, MA 01730
Party NameProgenics Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10007
Party NameProgenics Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10007

Trademark Events

Event DateEvent Description
Friday, October 11, 2019NEW APPLICATION ENTERED
Tuesday, October 15, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 13, 2020ASSIGNED TO EXAMINER
Friday, January 17, 2020EXAMINERS AMENDMENT -WRITTEN
Friday, January 17, 2020EXAMINERS AMENDMENT E-MAILED
Friday, January 17, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, January 17, 2020EXAMINER'S AMENDMENT ENTERED
Friday, January 17, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 21, 2020ASSIGNED TO LIE
Wednesday, February 5, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 25, 2020PUBLISHED FOR OPPOSITION
Tuesday, February 25, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 21, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, June 17, 2020TEAS STATEMENT OF USE RECEIVED
Wednesday, June 17, 2020TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, July 1, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 17, 2020DIVISIONAL REQUEST RECEIVED
Wednesday, July 1, 2020DIVISIONAL PROCESSING COMPLETE
Wednesday, June 17, 2020USE AMENDMENT FILED
Wednesday, July 1, 2020STATEMENT OF USE PROCESSING COMPLETE
Thursday, July 2, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, July 3, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 4, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, September 16, 2020ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, November 13, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, November 13, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 13, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, November 13, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, November 13, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, August 4, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, August 18, 2025TEAS SECTION 8 & 15 RECEIVED
Monday, December 1, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, December 1, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, December 1, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

pylarify detection monitoring cancer pharmaceutical preparations diagnosis diagnosing imaging agents radiopharmaceutical